{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:31:30Z","timestamp":1794479490340,"version":"4.9.1"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002803","name":"Cariplo Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022YY85P5"],"award-info":[{"award-number":["2022YY85P5"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.biopha.2026.119960","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:18:21Z","timestamp":1790817501000},"page":"119960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Therapeutic potential of positive allosteric modulators of AMPA receptors in brain disorders"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7844-8360","authenticated-orcid":false,"given":"Alessio","family":"Spinola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6386-2466","authenticated-orcid":false,"given":"Maria","family":"Italia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Gardoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119960_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1126\/science.aaw8250","article-title":"Architecture and subunit arrangement of native AMPA receptors elucidated by cryo-EM","volume":"364","author":"Zhao","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119960_bib2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuron.2018.10.018","article-title":"The AMPA receptor code of synaptic plasticity","volume":"100","author":"Diering","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119960_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tins.2007.01.006","article-title":"Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death","volume":"30","author":"Liu","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib4","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.neuron.2018.05.018","article-title":"Glutamatergic signaling in the central nervous system: ionotropic and metabotropic receptors in concert","volume":"98","author":"Reiner","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119960_bib5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nsmb.3214","article-title":"Structural mechanisms of activation and desensitization in neurotransmitter-gated ion channels","volume":"23","author":"Plested","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.biopha.2026.119960_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/pharmrev.120.000131","article-title":"Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels","volume":"73","author":"Hansen","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2026.119960_bib7","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1021\/bi8015907","article-title":"Flip and flop: a molecular determinant for AMPA receptor channel opening","volume":"48","author":"Pei","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2026.119960_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11571-026-10446-y","article-title":"Glutamate receptors as regulators of synaptic plasticity in neuropsychiatric disorders: pathological insight and translational perspectives","volume":"20","author":"Srivastava","year":"2026","journal-title":"Cogn. Neurodyn"},{"key":"10.1016\/j.biopha.2026.119960_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2025.173967","article-title":"Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to today","volume":"248","author":"Radin","year":"2025","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2026.119960_bib10","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0b013e318254473a","article-title":"Randomized phase III study 306","volume":"78","author":"Krauss","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2026.119960_bib11","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/00000542-199811000-00005","article-title":"AMPA\/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans","volume":"89","author":"Sang","year":"1998","journal-title":"Anesthesiology"},{"key":"10.1016\/j.biopha.2026.119960_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1124\/jpet.104.078196","article-title":"Positive \u03b1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Modulators Have Different Impact on Synaptic Transmission in the Thalamus and Hippocampus","volume":"313","author":"Xia","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2026.119960_bib13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neuroscience.2005.06.031","article-title":"AMPA receptor modulators have different impact on hippocampal pyramidal cells and interneurons","volume":"135","author":"Xia","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2026.119960_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/futurepharmacol5020027","article-title":"Recovery from AMPA Receptor Potentiation by Ampakines","volume":"5","author":"Radin","year":"2025","journal-title":"Future Pharmacol."},{"key":"10.1016\/j.biopha.2026.119960_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0006-8993(98)00446-6","article-title":"The waveform of synaptic transmission at hippocampal synapses is not determined by AMPA receptor desensitization","volume":"799","author":"Arai","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2026.119960_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/syn.22310","article-title":"High Impact AMPAkines Induce a Gq-Protein Coupled Endoplasmic Calcium Release in Cortical Neurons: A Possible Mechanism for Explaining the Toxicity of High Impact AMPAkines","volume":"78","author":"Radin","year":"2024","journal-title":"Synapse"},{"key":"10.1016\/j.biopha.2026.119960_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/jpet.113.204735","article-title":"Positive Allosteric Modulation of AMPA Receptors from Efficacy to Toxicity: The Interspecies Exposure-Response Continuum of the Novel Potentiator PF-4778574","volume":"347","author":"Shaffer","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2026.119960_bib18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2174\/138945007780618490","article-title":"Pharmacology of Ampakine Modulators: From AMPA Receptors to Synapses and Behavior","volume":"8","author":"Arai","year":"2007","journal-title":"Curr. Drug. Targets"},{"key":"10.1016\/j.biopha.2026.119960_bib19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/toxsci\/kfx277","article-title":"Brain Vacuolation Resulting From Administration of the Type II Ampakine CX717 Is An Artifact Related to Molecular Structure and Chemical Reaction With Tissue Fixative Agents","volume":"162","author":"Purcell","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.biopha.2026.119960_bib20","article-title":"Strictly regulated agonist-dependent activation of AMPA-R is the key characteristic of TAK-653 for robust synaptic responses and cognitive improvement","volume":"11","author":"Suzuki","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119960_bib21","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.neuroscience.2003.10.033","article-title":"Modulation of AMPA receptor kinetics differentially influences synaptic plasticity in the hippocampus","volume":"123","author":"Arai","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2026.119960_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s002130050386","article-title":"A profile of the behavioral changes produced by facilitation of AMPA-type glutamate receptors","volume":"133","author":"Davis","year":"1997","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.biopha.2026.119960_bib23","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1038\/s41467-018-04439-7","article-title":"The CaMKII\/NMDA receptor complex controls hippocampal synaptic transmission by kinase-dependent and independent mechanisms","volume":"9","author":"Incontro","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119960_bib24","doi-asserted-by":"crossref","first-page":"8688","DOI":"10.1523\/JNEUROSCI.6078-08.2009","article-title":"Positive AMPA Receptor Modulation Rapidly Stimulates BDNF Release and Increases Dendritic mRNA Translation","volume":"29","author":"Jourdi","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.biopha.2018.06.008","article-title":"Effects of chronic systemic low-impact ampakine treatment on neurotrophin expression in rat brain","volume":"105","author":"Radin","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119960_bib26","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neuropharm.2013.05.029","article-title":"Form follows function: BDNF and its involvement in sculpting the function and structure of synapses","volume":"76","author":"Zagrebelsky","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2026.119960_bib27","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.4037-06.2007","article-title":"Brain-derived neurotrophic factor promotes long-term potentiation-related cytoskeletal changes in adult hippocampus","volume":"27","author":"Rex","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-5949.2009.00088.x","article-title":"DRUG FOCUS: S 18986: a positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancer","volume":"16","author":"Bernard","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biopha.2026.119960_bib29","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1523\/JNEUROSCI.18-07-02748.1998","article-title":"Facilitative effects of the ampakine CX516 on short-term memory in rats: correlations with hippocampal neuronal activity","volume":"18","author":"Hampson","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib30","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1523\/JNEUROSCI.15-12-08023.1995","article-title":"Facilitation of olfactory learning by a modulator of AMPA receptors","volume":"15","author":"Larson","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00213-008-1325-2","article-title":"Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat","volume":"202","author":"Woolley","year":"2009","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.biopha.2026.119960_bib32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0006-8993(96)01049-9","article-title":"Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats","volume":"738","author":"Larson","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2026.119960_bib33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/exnr.1997.6581","article-title":"Enhancement by an ampakine of memory encoding in humans","volume":"146","author":"Ingvar","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2026.119960_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/exnr.1997.6447","article-title":"Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans","volume":"145","author":"Lynch","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2026.119960_bib35","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.npp.1301257","article-title":"Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers","volume":"32","author":"Wezenberg","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2026.119960_bib36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/cap.2006.16.525","article-title":"Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial","volume":"16","author":"Berry-Kravis","year":"2006","journal-title":"J. Child. Adolesc. Psychopharmacol."},{"key":"10.1016\/j.biopha.2026.119960_bib37","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1212\/01.wnl.0000260240.46070.7c","article-title":"AMPA potentiator treatment of cognitive deficits in Alzheimer disease","volume":"68","author":"Chappell","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2026.119960_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178047","article-title":"Low-impact ampakine CX717 exhibits promising therapeutic profile in adults with ADHD - A phase 2A clinical trial","volume":"1005","author":"Radin","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119960_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/cpdd.1475","article-title":"Safety, Tolerability, and Pharmacokinetic Profile of the Low-Impact Ampakine CX1739 in Young Healthy Volunteers","volume":"14","author":"Radin","year":"2025","journal-title":"Clin. Pharmacol. Drug. Dev."},{"key":"10.1016\/j.biopha.2026.119960_bib40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/futurepharmacol4010012","article-title":"Low-Impact Ampakine CX1739 Exerts Pro-Cognitive Effects and Reverses Opiate-Induced Respiratory Depression in Rodents","volume":"4","author":"Radin","year":"2024","journal-title":"Future Pharmacol."},{"key":"10.1016\/j.biopha.2026.119960_bib41","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.89767","article-title":"Acute ampakines increase voiding function and coordination in a rat model of SCI","volume":"12","author":"Rana","year":"2024","journal-title":"eLife"},{"key":"10.1016\/j.biopha.2026.119960_bib42","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41398-022-02148-w","article-title":"Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers","volume":"12","author":"Dijkstra","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.biopha.2026.119960_bib43","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1177\/0269881112458728","article-title":"Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial","volume":"26","author":"Nations","year":"2012","journal-title":"J. Psychopharmacol. (Oxf. )"},{"key":"10.1016\/j.biopha.2026.119960_bib44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mds.26479","article-title":"Synaptic failure and \u03b1-synuclein","volume":"31","author":"Calo","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2026.119960_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41573-023-00823-1","article-title":"Targeting synapse function and loss for treatment of neurodegenerative diseases","volume":"23","author":"Dejanovic","year":"2024","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.biopha.2026.119960_bib46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrneurol.2016.140","article-title":"Pathophysiological and diagnostic implications of cortical dysfunction in ALS","volume":"12","author":"Geevasinga","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2026.119960_bib47","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM199403033300907","article-title":"Excitatory amino acids as a final common pathway for neurologic disorders","volume":"330","author":"Lipton","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119960_bib48","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-\u03b2\u2013induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks","volume":"13","author":"Palop","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of \u03b1-synuclein aggregation in dementia with Lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathol. (Berl. )"},{"key":"10.1016\/j.biopha.2026.119960_bib50","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s Disease Is a Synaptic Failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119960_bib51","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.bbadis.2006.05.002","article-title":"The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis","volume":"1762","author":"Van Den Bosch","year":"2006","journal-title":"Biochim. Biophys. Acta BBA - Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2026.119960_bib52","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201898960","article-title":"Parkinson\u2019s disease: convergence on synaptic homeostasis","volume":"37","author":"Soukup","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2026.119960_bib53","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119960_bib54","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer\u2019s disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119960_bib55","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2026.119960_bib56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nbd.2015.10.019","article-title":"Soluble A\u03b2 Oligomers Impair Hippocampal LTP by Disrupting Glutamatergic\/GABAergic Balance","volume":"85","author":"Lei","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2026.119960_bib57","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","article-title":"Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake","volume":"62","author":"Li","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119960_bib58","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib59","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3233\/JAD-170879","article-title":"Amyloid-\u03b2 Induces AMPA receptor ubiquitination and degradation in primary neurons and human brains of Alzheimer\u2019s disease","volume":"62","author":"Zhang","year":"2018","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.biopha.2026.119960_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184429","article-title":"Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptors","volume":"12","author":"Bretin","year":"2017","journal-title":"PLoS. One"},{"key":"10.1016\/j.biopha.2026.119960_bib61","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.neuropharm.2017.06.009","article-title":"The AMPA receptor positive allosteric modulator S 47445 rescues in vivo CA3-CA1 long-term potentiation and structural synaptic changes in old mice","volume":"123","author":"Giralt","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2026.119960_bib62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.phrs.2017.04.019","article-title":"Upregulation of neurotrophins by S 47445, a novel positive allosteric modulator of AMPA receptors in aged rats","volume":"121","author":"Calabrese","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2026.119960_bib63","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3389\/fphar.2017.00462","article-title":"S 47445 Produces antidepressant- and anxiolytic-like effects through neurogenesis dependent and independent mechanisms","volume":"8","author":"Mendez-David","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119960_bib64","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bbi.2024.03.018","article-title":"Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features","volume":"118","author":"Italia","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.biopha.2026.119960_bib65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.trci.2019.04.002","article-title":"A 24-week double-blind placebo-controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer\u2019s disease and depressive symptoms","volume":"5","author":"Bernard","year":"2019","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.biopha.2026.119960_bib66","first-page":"724","article-title":"CX691, as an AMPA receptor positive modulator, improves the learning and memory in a rat model of Alzheimer\u2019s disease","volume":"21","author":"Mozafari","year":"2018","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"10.1016\/j.biopha.2026.119960_bib67","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1017\/S1041610212002141","article-title":"Mibampator (LY451395) randomized clinical trial for agitation\/aggression in Alzheimer\u2019s disease","volume":"25","author":"Trzepacz","year":"2013","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.biopha.2026.119960_bib68","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1124\/jpet.102.040360","article-title":"Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action","volume":"303","author":"Arai","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2026.119960_bib69","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/taap.2002.9534","article-title":"Positive Modulation of \u03b1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid-Type Glutamate Receptors Elicits Neuroprotection after Trimethyltin Exposure in Hippocampus","volume":"185","author":"Munirathinam","year":"2002","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119960_bib70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.expneurol.2008.07.010","article-title":"Ampakine CX516 ameliorates functional deficits in AMPA receptors in a hippocampal slice model of protein accumulation","volume":"214","author":"Kanju","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2026.119960_bib71","first-page":"1081","article-title":"CX-516 Cortex pharmaceuticals","volume":"3","author":"Danysz","year":"2002","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.biopha.2026.119960_bib72","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12031-002-0032-4","article-title":"Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine CX516 in elderly participants with mild cognitive impairment: a progress report","volume":"19","author":"Johnson","year":"2002","journal-title":"J. Mol. Neurosci. MN"},{"key":"10.1016\/j.biopha.2026.119960_bib73","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/ane.12189","article-title":"Cognitive impairment in early-stage non-demented Parkinson\u2019s disease patients","volume":"129","author":"Pfeiffer","year":"2014","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.biopha.2026.119960_bib74","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2026.119960_bib75","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119960_bib76","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00702-012-0840-9","article-title":"Early diagnosis and therapy of Parkinson\u2019s disease: can disease progression be curbed?","volume":"120","author":"Kansara","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.biopha.2026.119960_bib77","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib78","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1113\/jphysiol.2006.105510","article-title":"Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons","volume":"572","author":"Ivanov","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.biopha.2026.119960_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1276376","article-title":"Treatment of Parkinson\u2019s disease with biologics that penetrate the blood-brain barrier via receptor-mediated transport","volume":"15","author":"Pardridge","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib80","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3889300","article-title":"Brain-derived neurotrophic factor and nerve growth factor therapeutics for brain injury: the current translational challenges in preclinical and clinical research","volume":"2022","author":"Sims","year":"2022","journal-title":"Neural Plast."},{"key":"10.1016\/j.biopha.2026.119960_bib81","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coph.2014.10.011","article-title":"Targeting glutamatergic synapses in Parkinson\u2019s disease","volume":"20","author":"Gardoni","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119960_bib82","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0028-3908(01)00040-5","article-title":"Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro","volume":"40","author":"Gates","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2026.119960_bib83","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0028-3908(01)00031-4","article-title":"Potentiation of responses to AMPA on central neurones by LY392098 and LY404187 in vivo","volume":"40","author":"Vandergriff","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2026.119960_bib84","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neulet.2012.10.020","article-title":"LY404187, a potentiator of AMPARs, enhances both the amplitude and 1\/CV2 of AMPA EPSCs but not NMDA EPSCs at CA3\u2013CA1 synapses in the hippocampus of neonatal rats","volume":"531","author":"Song","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2026.119960_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0028-3908(02)00066-7","article-title":"An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study","volume":"43","author":"Mackowiak","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2026.119960_bib86","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0028-3908(01)00027-2","article-title":"Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro","volume":"40","author":"Miu","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2026.119960_bib87","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2003.12.023","article-title":"Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson\u2019s disease","volume":"486","author":"O\u2019Neill","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119960_bib88","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1527-3458.2005.tb00037.x","article-title":"LY503430: Pharmacology, Pharmacokinetics, and Effects in Rodent Models of Parkinson\u2019s Disease","volume":"11","author":"O\u2019Neill","year":"2005","journal-title":"CNS Drug. Rev."},{"key":"10.1016\/j.biopha.2026.119960_bib89","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1124\/jpet.103.049445","article-title":"LY503430, a Novel \u03b1-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson\u2019s Disease","volume":"306","author":"Murray","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2026.119960_bib90","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/jpet.106.105734","article-title":"Pharmacological Characterization of cGMP Regulation by the Biarylpropylsulfonamide Class of Positive, Allosteric Modulators of \u03b1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors","volume":"319","author":"Ryder","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2026.119960_bib91","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.54.8.1589","article-title":"AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys","volume":"54","author":"Konitsiotis","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2026.119960_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108744","article-title":"Pharmacological modulation of respiratory control: Ampakines as a therapeutic strategy","volume":"265","author":"Rana","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2026.119960_bib93","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.neuropharm.2009.01.015","article-title":"BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices","volume":"56","author":"Jourdi","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2026.119960_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148448","article-title":"Ampakine CX614 increases respiratory rate in a mouse model of Parkinson\u2019s disease","volume":"1815","author":"Oliveira","year":"2023","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2026.119960_bib95","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119960_bib96","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2026.119960_bib97","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2026.119960_bib98","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/hmg\/ddl224","article-title":"Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington\u2019s disease","volume":"15","author":"Cummings","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2026.119960_bib99","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","article-title":"Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington\u2019s disease mutation","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci. J. Soc. Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin Controls Neurotrophic Support and Survival of Neurons by Enhancing BDNF Vesicular Transport along Microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119960_bib101","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","article-title":"Brain-derived neurotrophic factor in Huntington disease","volume":"866","author":"Ferrer","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2026.119960_bib102","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1038\/s41467-018-06675-3","article-title":"Modulation of AMPA receptor surface diffusion restores hippocampal plasticity and memory in Huntington\u2019s disease models","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119960_bib103","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1073\/pnas.0811228106","article-title":"Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington\u2019s disease knockin mice","volume":"106","author":"Simmons","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2026.119960_bib104","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.nbd.2010.10.015","article-title":"Brief ampakine treatments slow the progression of Huntington\u2019s disease phenotypes in R6\/2 mice","volume":"41","author":"Simmons","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2026.119960_bib105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/71555","article-title":"Glutamate excitotoxicity in a model of multiple sclerosis","volume":"6","author":"Pitt","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2026.119960_bib106","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(16)31320-4","article-title":"Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function","volume":"389","author":"Ontaneda","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119960_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1532877","article-title":"Positive allosteric modulation of AMPA receptors via PF4778574 leads to reduced demyelination and clinical disability in experimental models of multiple sclerosis","volume":"16","author":"Sindi","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119960_bib108","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2026.119960_bib109","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41583-018-0006-3","article-title":"Rett syndrome: insights into genetic, molecular and circuit mechanisms","volume":"19","author":"Ip","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/mds.22851","article-title":"Stereotypical hand movements in 144 subjects with Rett syndrome from the population-based Australian database","volume":"25","author":"Carter","year":"2010","journal-title":"Mov. Disord. J. Mov. Disord. Soc."},{"key":"10.1016\/j.biopha.2026.119960_bib111","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/pcn.13299","article-title":"Movement disorders in patients with Rett syndrome: A systematic review of evidence and associated clinical considerations","volume":"75","author":"Singh","year":"2021","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib112","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1016\/j.ridd.2013.06.040","article-title":"Early socio-communicative forms and functions in typical Rett syndrome","volume":"34","author":"Bartl-Pokorny","year":"2013","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.biopha.2026.119960_bib113","doi-asserted-by":"crossref","first-page":"253","DOI":"10.31887\/DCNS.2012.14.3\/jneul","article-title":"The relationship of Rett syndrome and MECP2 disorders to autism","volume":"14","author":"Neul","year":"2012","journal-title":"Dialog.-. Clin. Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib114","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.braindev.2018.03.010","article-title":"The course of awake breathing disturbances across the lifespan in Rett syndrome","volume":"40","author":"Tarquinio","year":"2018","journal-title":"Brain Dev."},{"key":"10.1016\/j.biopha.2026.119960_bib115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/cne.22009","article-title":"Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks","volume":"514","author":"Belichenko","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.biopha.2026.119960_bib116","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/cercor\/bhv002","article-title":"Mechanisms of Functional Hypoconnectivity in the Medial Prefrontal Cortex of Mecp2 Null Mice","volume":"26","author":"Sceniak","year":"2016","journal-title":"Cereb. Cortex N. Y NY"},{"key":"10.1016\/j.biopha.2026.119960_bib117","doi-asserted-by":"crossref","first-page":"12560","DOI":"10.1073\/pnas.0506071102","article-title":"Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome","volume":"102","author":"Dani","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119960_bib118","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.expneurol.2009.05.001","article-title":"Neuronal differentiation of neural precursor cells is promoted by the methyl-CpG-binding protein MeCP2","volume":"219","author":"Tsujimura","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2026.119960_bib119","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1460-9568.2012.08072.x","article-title":"Ampakine CX546 increases proliferation and neuronal differentiation in subventricular zone stem\/progenitor cell cultures","volume":"35","author":"Schitine","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib120","doi-asserted-by":"crossref","first-page":"10912","DOI":"10.1523\/JNEUROSCI.1869-07.2007","article-title":"Brain-Derived Neurotrophic Factor Expression and Respiratory Function Improve after Ampakine Treatment in a Mouse Model of Rett Syndrome","volume":"27","author":"Ogier","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib121","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012433","article-title":"The enhancement of activity rescues the establishment of Mecp2 null neuronal phenotypes","volume":"13","author":"Scaramuzza","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biopha.2026.119960_bib122","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/ajmg.a.32439","article-title":"Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey","volume":"146A","author":"Bailey","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.biopha.2026.119960_bib123","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajmg.a.30229","article-title":"Autism spectrum disorder in fragile X syndrome: communication, social interaction, and specific behaviors","volume":"129A","author":"Kaufmann","year":"2004","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.biopha.2026.119960_bib124","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ajmg.1320300118","article-title":"Cognitive profiles of boys with the fragile X syndrome","volume":"30","author":"Kemper","year":"1988","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.biopha.2026.119960_bib125","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0092-8674(91)90283-5","article-title":"Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox","volume":"67","author":"Fu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119960_bib126","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/hmg\/10.14.1449","article-title":"Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers","volume":"10","author":"Kenneson","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2026.119960_bib127","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1601-183X.2005.00128.x","article-title":"Localization of FMRP-associated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons","volume":"4","author":"Antar","year":"2005","journal-title":"Genes. Brain Behav."},{"key":"10.1016\/j.biopha.2026.119960_bib128","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7692601","article-title":"FMR1 Protein: Conserved RNP Family Domains and Selective RNA Binding","volume":"262","author":"Ashley","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119960_bib129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119960_bib130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/cercor\/bht237","article-title":"Rescue of NMDAR-Dependent Synaptic Plasticity in Fmr1 Knock-Out Mice","volume":"25","author":"Bostrom","year":"2015","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.biopha.2026.119960_bib131","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.neuron.2006.07.005","article-title":"Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression","volume":"51","author":"Hou","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119960_bib132","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/cercor\/10.10.1038","article-title":"WT. Dendritic Spine Structural Anomalies in Fragile-X Mental Retardation Syndrome","volume":"10","author":"Irwin","year":"2000","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.biopha.2026.119960_bib133","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neuron.2005.07.005","article-title":"Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome","volume":"47","author":"Koekkoek","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119960_bib134","doi-asserted-by":"crossref","first-page":"10685","DOI":"10.1523\/JNEUROSCI.2624-07.2007","article-title":"Brain-Derived Neurotrophic Factor Rescues Synaptic Plasticity in a Mouse Model of Fragile X Syndrome","volume":"27","author":"Lauterborn","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104604","article-title":"A TrkB agonist and ampakine rescue synaptic plasticity and multiple forms of memory in a mouse model of intellectual disability","volume":"134","author":"Seese","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2026.119960_bib136","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1038\/s41467-019-10910-w","article-title":"AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders","volume":"10","author":"Salpietro","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119960_bib137","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/brain\/awad403","article-title":"Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes","volume":"147","author":"Rinaldi","year":"2024","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.biopha.2026.119960_bib138","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ajhg.2017.11.004","article-title":"De Novo Variants in GRIA4 Lead to Intellectual Disability with or without Seizures and Gait Abnormalities","volume":"101","author":"Martin","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biopha.2026.119960_bib139","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/cge.14577","article-title":"Unraveling GRIA1 neurodevelopmental disorders: Lessons learned from the p.(Ala636Thr) variant","volume":"106","author":"Tvergaard","year":"2024","journal-title":"Clin. Genet."},{"key":"10.1016\/j.biopha.2026.119960_bib140","doi-asserted-by":"crossref","first-page":"19034","DOI":"10.1523\/JNEUROSCI.2454-13.2013","article-title":"Calcium-Permeable AMPA Receptors in the Nucleus Accumbens Regulate Depression-Like Behaviors in the Chronic Neuropathic Pain State","volume":"33","author":"Goffer","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib141","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature06995","article-title":"Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving","volume":"454","author":"Conrad","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119960_bib142","first-page":"2026","article-title":"Discovery of GluA3 preferring AMPA receptor positive allosteric modulator","volume":"3290","author":"Greaves","year":"2026","journal-title":"BRD"},{"key":"10.1016\/j.biopha.2026.119960_bib143","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0896-6273(91)90176-Z","article-title":"Glutamate-operated channels: Developmentally early and mature forms arise by alternative splicing","volume":"6","author":"Monyer","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119960_bib144","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1523\/JNEUROSCI.2293-22.2023","article-title":"Alternative Splicing of the Flip\/Flop Cassette and TARP Auxiliary Subunits Engage in a Privileged Relationship That Fine-Tunes AMPA Receptor Gating","volume":"43","author":"Perozzo","year":"2023","journal-title":"J. Neurosci. J. Soc. Neurosci."},{"key":"10.1016\/j.biopha.2026.119960_bib145","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1083\/jcb.200212116","article-title":"Functional studies and distribution define a family of transmembrane AMPA receptor regulatory proteins","volume":"161","author":"Tomita","year":"2003","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.biopha.2026.119960_bib146","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1124\/jpet.118.250126","article-title":"Modulation of TARP \u03b38-Containing AMPA Receptors as a Novel Therapeutic Approach for Chronic Pain","volume":"369","author":"Knopp","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2026.119960_bib147","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/epi4.70294","article-title":"A first in disease trial of the safety, tolerability, and anti-seizure effects of ES-481 in drug-resistant epilepsy","volume":"11","author":"Foster","year":"2026","journal-title":"Epilepsia Open."},{"key":"10.1016\/j.biopha.2026.119960_bib148","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41398-021-01451-2","article-title":"Transcranial magnetic stimulation as a translational biomarker for AMPA receptor modulation","volume":"11","author":"O\u2019Donnell","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.biopha.2026.119960_bib149","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/jmri.70160","article-title":"Pharmacological MRI: utility in understanding drug mechanisms in psychiatric disorders","volume":"63","author":"Sander","year":"2026","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.biopha.2026.119960_bib150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jamapsychiatry.2017.3572","article-title":"Utility of imaging-based biomarkers for glutamate-targeted drug development in psychotic disorders","volume":"75","author":"Javitt","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopha.2026.119960_bib151","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","article-title":"Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study","volume":"22","author":"Siderowf","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2026.119960_bib152","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","article-title":"Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.biopha.2026.119960_bib153","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41591-019-0723-9","article-title":"Visualization of AMPA receptors in living human brain with positron emission tomography","volume":"26","author":"Miyazaki","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2026.119960_bib154","article-title":"Dynamics of AMPA receptors regulate epileptogenesis in patients with epilepsy","volume":"4","author":"Eiro","year":"2023","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.biopha.2026.119960_bib155","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/s41380-024-02785-1","article-title":"Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomography","volume":"30","author":"Hatano","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.biopha.2026.119960_bib156","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41380-026-03510-w","article-title":"The dynamics of AMPA receptors underlies the efficacy of ketamine in treatment resistant patients with depression","volume":"31","author":"Nakajima","year":"2026","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.biopha.2026.119960_bib157","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.euroneuro.2014.01.001","article-title":"Modafinil combined with cognitive training is associated with improved learning in healthy volunteers--a randomised controlled trial","volume":"24","author":"Gilleen","year":"2014","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2026.119960_bib158","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1038\/s41380-026-03527-1","article-title":"NADPH oxidase-1 suppression prolongs the antidepressant-like effect of ketamine","volume":"31","author":"Nakajima","year":"2026","journal-title":"Mol. Psychiatry"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:56:24Z","timestamp":1794477384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226009960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":158,"alternative-id":["S0753332226009960"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119960","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of positive allosteric modulators of AMPA receptors in brain disorders","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119960"}}